Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Hair transplantation has improved to more natural-looking results and is complemented by effective non-surgical treatments, with ongoing research into hair follicle cloning.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Finasteride and minoxidil together work best for male hair loss.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

The BASP classification is effective for diagnosing pattern hair loss in Indian men and women.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Lymecycline may help with Frontal Fibrosing Alopecia but needs more research.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Hair loss severity relates to increased miniaturization in female pattern hair loss.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.